John Parkinson is the assistant managing editor for Contagion. Prior to joining MJH Life Sciences in 2020, he has covered a variety of fields and markets including diabetes, oncology, ophthalmology, IT, travel, and local news. You can email him at jparkinson@mjhlifesciences.com.
Sigyn Therapeutics Looking to Reduce Effects of Cytokine Storm With Blood Purification Technology
October 19th 2021The company’s current investigational medical device, Sigyn Therapy, is a novel medical device that is being studied for addressing viral pathogens and bacterial toxins to avoid this massive inflammation onslaught and the potential of sepsis.
Read More
Diagnostic Stewardship: Appropriate Testing Leads to Efficient Diagnosis, Timely Therapy
October 1st 2021This type of stewardship is a means of reducing unnecessary testing, getting the appropriate diagnosis more efficiently, and getting patients the appropriate therapy in a timely manner.
Read More
Understanding the Medical Needs Associated With Transgender Health
September 27th 2021The Fenway Institute is hosting its upcoming Advancing Excellence in Transgender Health conference. The program will include education on transgender medical care as well as how clinicians and people within this community can interact and the former can understand the latter’s needs when it comes to preventative and acute care.
Read More
FDA Committee Votes to Recommend EUA of COVID-19 Booster Dose in Older, High-Risk People
September 17th 2021After voting against recommendation of a booster dose for people 16 years and older, the committee created a new question to vote on an EUA for a booster dose for people 65 years and older and those at high risk of COVID-19. They voted 18-0 in favor.
Read More